Single-nucleus RNA sequencing uncovers cell type-specific alterations in OSA-related liver injury

单核RNA测序揭示OSA相关肝损伤中细胞类型特异性改变

阅读:2

Abstract

Chronic intermittent hypoxia (CIH), a hallmark feature of obstructive sleep apnea (OSA), is strongly implicated in the development of hepatic injury. However, the cellular mechanisms underlying CIH-induced liver dysfunction remain poorly understood. This study aimed to systematically characterize hepatic cellular responses to CIH at single-nucleus resolution. A rodent model of CIH was established and subjected to histological and transcriptomic analyses. Single-nucleus RNA sequencing (snRNA-seq) was performed to delineate transcriptional alterations across liver cell populations. Differentially expressed genes (DEGs) and pathway enrichment analyses were conducted to identify key biological processes and signaling networks affected by CIH exposure. CIH exposure resulted in marked hepatic injury characterized by spotty necrosis and prominent infiltration of inflammatory cells. SnRNA-seq identified ten major liver cell types with stable composition but revealed extensive transcriptional reprogramming across multiple hepatic subpopulations. CIH suppressed PPAR signaling and fatty acid metabolism in hepatocytes and hepatic stellate cells and activated AMPK and PI3K-Akt pathways related to stress response and fibrogenic processes. Mononuclear phagocytes showed upregulation of NF-κB signaling and complement/coagulation cascades. Endothelial cells exhibited changes in genes associated with cytoskeletal organization and tight junctions. T cell subpopulations displayed altered expression of genes involved in metabolic regulation and endoplasmic reticulum stress. This study provides the first single-nucleus transcriptomic atlas of the liver under CIH, revealing cell type-specific molecular remodeling across hepatocytes, stromal, and immune cells. These findings elucidate the complex cellular interplay associated with CIH-induced hepatic injury and offer novel insights into potential therapeutic targets for OSA-related liver dysfunction.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。